Private Advisor Group, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Private Advisor Group, LLC

  • $15.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 02, 2020
SELL
$2.97 - $5.08 $127,264 - $217,678
-42,850 Closed
0 $0
Q2 2020

Aug 17, 2020
SELL
$3.48 - $5.05 $34,135 - $49,535
-9,809 Reduced 18.63%
42,850 $198,000
Q1 2020

May 12, 2020
SELL
$2.61 - $5.21 $39,150 - $78,150
-15,000 Reduced 22.17%
52,659 $203,000
Q4 2019

Feb 10, 2020
BUY
$3.67 - $5.7 $63,307 - $98,325
17,250 Added 34.22%
67,659 $254,000
Q3 2019

Nov 13, 2019
BUY
$3.89 - $7.43 $196,091 - $374,538
50,409 New
50,409 $268,000

Others Institutions Holding CPRX

# of Institutions
326
Shares Held
94.6M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.12B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email